Genetic analysis of 13 families with X-linked chronic granulomatous disease reveals a low proportion of sporadic patients and a high proportion of sporadic carriers

Pediatr Res. 1998 Jul;44(1):85-92. doi: 10.1203/00006450-199807000-00014.

Abstract

X-linked chronic granulomatous disease (X-CGD) is the most common type of CGD, whose responsible gene has been identified and termed as CYBB, according to the gp91-phox, a subunit of cytochrome b558. Although approximately 200 different mutations of the gp91-phox gene have been reported, no precise study of the proportion of sporadic cases in X-CGD, based on molecular genetic analysis, has been reported. We made a genetic analysis of six newly identified X-CGD patients together with that of eight previously reported X-CGD patients. The mutations newly detected were three missense mutations, two splice mutations, and one insertion of 2 bases. All of the mutations were novel. Twelve mothers (two of them came from the same family) and four maternal grandmothers from 13 different X-CGD families were available for further genetic studies. It was revealed that a proportion of sporadic patients was low and that of sporadic carriers was high. These results suggest that the mutation for the disease originates mainly from male gametes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alternative Splicing
  • Amino Acid Sequence
  • Base Sequence
  • DNA Primers
  • DNA Transposable Elements
  • Exons
  • Family
  • Female
  • Genetic Carrier Screening
  • Genomic Imprinting*
  • Granulomatous Disease, Chronic / genetics*
  • Humans
  • Male
  • Membrane Glycoproteins / genetics*
  • Mutation*
  • NADPH Oxidase 2
  • NADPH Oxidases*
  • Point Mutation
  • Polymerase Chain Reaction / methods
  • X Chromosome*

Substances

  • DNA Primers
  • DNA Transposable Elements
  • Membrane Glycoproteins
  • CYBB protein, human
  • NADPH Oxidase 2
  • NADPH Oxidases